Britest is playing a crucial linking and communications role in a a new four-year European project that will contribute to the sustainable development of pharmaceuticals, by using and promoting lifecycle approaches to their design, manufacture, usage, and disposal
A new 2-minute-to-watch video explains how Britest's roadmap for digital design development and application can be used by organisations in the chemicals-using and process industries to successfully plan for a rapid and effective business introduction of new ways of working based upon emerging digital and modelling based process design, development and control methods.
COVID-19 lockdown has turned out to be a catalyst for insightful reflection upon the subject of pharmaceutical plant cleaning operations on the part of Britest's Rob Peeling. His detailed analysis of relevant driving forces and conclusions which challenge received industrial wisdom and typical practice can be read in full in this freely available Britest white paper.
Article on digital information flows goes open access A new publication describing how new digital models and approaches have been mapped onto the information workflow involved in pharmaceutical product and process design and development via a Britest-developed dedicated technical
A new publication arising from the ADDoPT project collaboration describes how a combination of existing and novel approaches has been applied to the assessment and prediction of particle properties intrinsic to the formulation and manufacture of pharmaceuticals via a new, robust workflow applying predictive digital design tools built around the CSD-System software suite.
Symposium Report - Continuous Flow Chemistry for Industrial Processes RSC Symposium, ChemSpec Europe, Münich, Germany, 31st May – 1st June 2017 The production of fine and speciality chemicals is still heavily reliant on batch processes. There is much technology innovation being developed
Britest CEO in the chair at International Continuous Flow Chemistry Symposium Gareth Jenkins to chair session at RSC event during Chemspec 2017 Britest Limited is pleased to report that our Chief Executive Officer Dr. Gareth Jenkins will be chairing a session at a forthcoming Royal Society
New £20.4m project set to transform UK pharmaceutical development and manufacturing Britest is playing a key role in a newly launched major collaborative project that is set to transform the UK pharmaceutical industry by enabling the manufacturing processes of the innovative medicines of the
Britest to partner in £22m REMEDIES project Britest’s role in the REMEDIES (RE-configuring MEDIcines End-to-end Supply) project will help the UK pharmaceutical industry develop enhanced process understanding to improve medicines manufacturing and supply. The project was launched in 2014 and has